Literature DB >> 31705233

[Individualization of the surgical procedure in response to overdiagnosis and overtreatment in differentiated thyroid carcinomas].

J I Staubitz1, T J Musholt2.   

Abstract

BACKGROUND: Advances in diagnostic methods have led to an early detection of thyroid nodules with debatable malignant potential in numerous cases. This can result in a potential overtreatment of thyroid lesions with very good prognosis.
OBJECTIVES: To avoid surgical overtreatment, an individualized, risk-adapted management is required that respects the different tumor biology of the underlying histological entities.
METHODS: The current guidelines of the leading professional societies, the American Thyroid Association (ATA) and the German Association of Endocrine Surgeons (CAEK), were compared and critically studied, to describe risk-adapted, more conservative treatment options for certain types of thyroid neoplasms according to the 2017 WHO definition.
RESULTS: The German CAEK recommends thyroidectomy as a routine operation in the case of thyroid carcinoma. Exceptions are papillary thyroid microcarcinoma and minimally invasive follicular thyroid carcinoma, which can be treated by lobectomy. The ATA proposes an "active surveillance" for papillary thyroid microcarcinoma and lobectomy in cases of differentiated thyroid carcinoma <4 cm in diameter in the absence of clearly predefined risk factors.
CONCLUSIONS: The pre- or intraoperative pathological diagnosis of the underlying tumor entity is the key point, which allows for an adaption of the resection strategy for thyroid malignancy. Depending on the type of carcinoma, the current guidelines of international expert societies allow for parenchyma-sparing operations and, according to the ATA, even an "active surveillance."

Entities:  

Keywords:  Active surveillance; Follicular thyroid carcinoma; Papillary thyroid carcinoma; Thyroidectomy

Mesh:

Year:  2019        PMID: 31705233     DOI: 10.1007/s00292-019-00699-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

Review 1.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

2.  [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].

Authors:  Markus Dietlein; Wolfgang Eschner; Frank Grünwald; Michael Lassmann; Frederik A Verburg; Markus Luster
Journal:  Nuklearmedizin       Date:  2016-06-28       Impact factor: 1.379

3.  Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer.

Authors:  Gabriel Glockzin; Matthias Hornung; Klaus Kienle; Katrin Thelen; Marita Boin; Andreas G Schreyer; Hamid R Lighvani; Hans J Schlitt; Ayman Agha
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

4.  Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Freddie Bray; Christopher P Wild; Martyn Plummer; Luigino Dal Maso
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

Review 5.  Gene Fusions in Thyroid Cancer.

Authors:  Valentina D Yakushina; Larisa V Lerner; Alexander V Lavrov
Journal:  Thyroid       Date:  2018-02       Impact factor: 6.568

Review 6.  Follicular cell-derived thyroid cancer.

Authors:  Henning Dralle; Andreas Machens; Johanna Basa; Vahab Fatourechi; Silvia Franceschi; Ian D Hay; Yuri E Nikiforov; Furio Pacini; Janice L Pasieka; Steven I Sherman
Journal:  Nat Rev Dis Primers       Date:  2015-12-10       Impact factor: 52.329

7.  Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.

Authors:  Reza Asari; Oskar Koperek; Christian Scheuba; Philipp Riss; Klaus Kaserer; Martha Hoffmann; Bruno Niederle
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

8.  FNA cytology and frozen section examination in patients with follicular lesions of the thyroid gland.

Authors:  Franco Lumachi; Simonetta Borsato; Alberto Tregnaghi; Filippo Marino; Francesco Polistina; Stefano M M Basso; Haralabos Koussis; Umberto Basso; Ambrogio Fassina
Journal:  Anticancer Res       Date:  2009-12       Impact factor: 2.480

9.  Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.

Authors:  Seong-Keun Yoo; Seungbok Lee; Su-Jin Kim; Hyeon-Gun Jee; Byoung-Ae Kim; Hyesun Cho; Young Shin Song; Sun Wook Cho; Jae-Kyung Won; Jong-Yeon Shin; Do Joon Park; Jong-Il Kim; Kyu Eun Lee; Young Joo Park; Jeong-Sun Seo
Journal:  PLoS Genet       Date:  2016-08-05       Impact factor: 5.917

10.  Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.

Authors:  Rengyun Liu; Tao Zhang; Guangwu Zhu; Mingzhao Xing
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

View more
  1 in total

1.  Thyroid surgery in children and young adults: potential overtreatment and complications.

Authors:  Julia I Staubitz; Julia Bode; Alicia Poplawski; Felix Watzka; Joachim Pohlenz; Hauke Lang; Thomas J Musholt
Journal:  Langenbecks Arch Surg       Date:  2020-05-27       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.